Limitations include the retrospective design and the inability to distinguish FR-β expression from immune cell infiltration.<h4>Conclusions</h4>Our large-scale study of transcriptome demonstrates FOLR2 gene expression is associated with aggressive prostate cancer in samples with low expression of PSMA. This evidence concerns the gene FOLH1 and prostate cancer.